Genomic Analysis of Abnormal DNAM Methylation in Parathyroid Tumors

Background. Parathyroid tumors are common endocrine neoplasias associated with primary hyperparathyroidism. Although numerous studies have studied the subject, the predictive value of gene biomarkers nevertheless remains low. Methods. In this study, we performed genomic analysis of abnormal DNA meth...

Full description

Saved in:
Bibliographic Details
Main Authors: Qing Li, Yonghao Li, Ximei Sun, Xinlei Zhang, Mei Zhang
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:International Journal of Endocrinology
Online Access:http://dx.doi.org/10.1155/2022/4995196
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832558413090914304
author Qing Li
Yonghao Li
Ximei Sun
Xinlei Zhang
Mei Zhang
author_facet Qing Li
Yonghao Li
Ximei Sun
Xinlei Zhang
Mei Zhang
author_sort Qing Li
collection DOAJ
description Background. Parathyroid tumors are common endocrine neoplasias associated with primary hyperparathyroidism. Although numerous studies have studied the subject, the predictive value of gene biomarkers nevertheless remains low. Methods. In this study, we performed genomic analysis of abnormal DNA methylation in parathyroid tumors. After data preprocessing, differentially methylated genes were extracted from patients with parathyroid tumors by using t-tests. Results. After refinement of the basic differential methylation, 28241 unique CpGs (634 genes) were identified to be methylated. The methylated genes were primarily involved in 7 GO terms, and the top 3 terms were associated with cyst morphogenesis, ion transport, and GTPase signal. Following pathway enrichment analyses, a total of 10 significant pathways were enriched; notably, the top 3 pathways were cholinergic synapses, glutamatergic synapses, and oxytocin signaling pathways. Based on PPIN and ego-net analysis, 67 ego genes were found which could completely separate the diseased group from the normal group. The 10 most prominent genes included POLA1, FAM155 B, AMMECR1, THOC2, CCND1, CLDN11, IDS, TST, RBPJ, and GNA11. SVM analysis confirmed that this grouping approach was precise. Conclusions. This research provides useful data to further explore novel genes and pathways as therapeutic targets for parathyroid tumors.
format Article
id doaj-art-c88b64cdf49b4d0f868ccd4d05645ae8
institution Kabale University
issn 1687-8345
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series International Journal of Endocrinology
spelling doaj-art-c88b64cdf49b4d0f868ccd4d05645ae82025-02-03T01:32:27ZengWileyInternational Journal of Endocrinology1687-83452022-01-01202210.1155/2022/4995196Genomic Analysis of Abnormal DNAM Methylation in Parathyroid TumorsQing Li0Yonghao Li1Ximei Sun2Xinlei Zhang3Mei Zhang4Department of General SurgeryDepartment of General SurgeryDepartment of General SurgeryDepartment of General SurgeryDepartment of General SurgeryBackground. Parathyroid tumors are common endocrine neoplasias associated with primary hyperparathyroidism. Although numerous studies have studied the subject, the predictive value of gene biomarkers nevertheless remains low. Methods. In this study, we performed genomic analysis of abnormal DNA methylation in parathyroid tumors. After data preprocessing, differentially methylated genes were extracted from patients with parathyroid tumors by using t-tests. Results. After refinement of the basic differential methylation, 28241 unique CpGs (634 genes) were identified to be methylated. The methylated genes were primarily involved in 7 GO terms, and the top 3 terms were associated with cyst morphogenesis, ion transport, and GTPase signal. Following pathway enrichment analyses, a total of 10 significant pathways were enriched; notably, the top 3 pathways were cholinergic synapses, glutamatergic synapses, and oxytocin signaling pathways. Based on PPIN and ego-net analysis, 67 ego genes were found which could completely separate the diseased group from the normal group. The 10 most prominent genes included POLA1, FAM155 B, AMMECR1, THOC2, CCND1, CLDN11, IDS, TST, RBPJ, and GNA11. SVM analysis confirmed that this grouping approach was precise. Conclusions. This research provides useful data to further explore novel genes and pathways as therapeutic targets for parathyroid tumors.http://dx.doi.org/10.1155/2022/4995196
spellingShingle Qing Li
Yonghao Li
Ximei Sun
Xinlei Zhang
Mei Zhang
Genomic Analysis of Abnormal DNAM Methylation in Parathyroid Tumors
International Journal of Endocrinology
title Genomic Analysis of Abnormal DNAM Methylation in Parathyroid Tumors
title_full Genomic Analysis of Abnormal DNAM Methylation in Parathyroid Tumors
title_fullStr Genomic Analysis of Abnormal DNAM Methylation in Parathyroid Tumors
title_full_unstemmed Genomic Analysis of Abnormal DNAM Methylation in Parathyroid Tumors
title_short Genomic Analysis of Abnormal DNAM Methylation in Parathyroid Tumors
title_sort genomic analysis of abnormal dnam methylation in parathyroid tumors
url http://dx.doi.org/10.1155/2022/4995196
work_keys_str_mv AT qingli genomicanalysisofabnormaldnammethylationinparathyroidtumors
AT yonghaoli genomicanalysisofabnormaldnammethylationinparathyroidtumors
AT ximeisun genomicanalysisofabnormaldnammethylationinparathyroidtumors
AT xinleizhang genomicanalysisofabnormaldnammethylationinparathyroidtumors
AT meizhang genomicanalysisofabnormaldnammethylationinparathyroidtumors